Orion Laboratories Pty Ltd T/A Perrigo Australia
Regulatory activities for this sponsor.
Loading...
Sponsor content
313 result(s) found, displaying 81 to 90
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Progesterone
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Prescription medicine registrationActive ingredients: progesterone.
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia